Welcome to Radiation Oncology

Chair's Message

Hak Choy, MD
Hak Choy, M.D.

The mission of this department is three-fold: to deliver world-class care on a daily basis to our patients using the most advanced technologies available; to conduct groundbreaking basic, translational and clinical research; and to provide quality education to the next generation of medical practitioners and scientists.

Recent News

Live web cam of new East Campus Radiation Oncology Center

Watch live! New Radiation Oncology center under construction

A live web cam has been added to the construction site of UT Southwestern's new $66 million Radiation Oncology treatment facility. Follow the link to view our progress. Watch Live

Research shows 98% cure rate for prostate cancer using Stereotactic Body Radiation Therapy

A five-year study shows that Stereotactic Body Radiation Therapy (SBRT) given in five sessions offers a higher cure rate for prostate cancer than more traditional approaches.

Department makes heavy ion grant awards

The Department of Radiation Oncology at UT Southwestern Medical Center has awarded five, two-year seed grants of $100,000 apiece to Texas researchers to facilitate research related to heavy ion therapy.

NASA awards funds to study effects of space radiation during Mars mission

UT Southwestern Medical Center researchers have been awarded $3.6 million in NASA funds to study how space radiation would affect the cancer risk of astronauts taking part in deep space missions to Mars.

Surgery vs. SABR: "Stablemates" trial to directly compare treatment in operable cancer patients

The results of a national trial evaluating stereotactic ablative radiotherapy (SABR) in lung cancer patients too frail to receive surgery were so positive that physicians have opened a multi-institutional trial to directly compare surgery vs. SABR in operable patients.

Physician discusses stereotactic combination therapy with WFAA/Ch 8

Dr. Robert Timmerman, Professor and Medical Director of Radiation Oncology, explains why treating cancer with a combination of stereotactic radiation and immunotherapy drugs is of increasing interest to researchers, in the wake of former president Jimmy Carter's cancer cure.

View All